# Adicet Bio, Inc.: Form SCHEDULE 13D/A, filed Apr 10, 2026

- Company: [Adicet Bio, Inc.](/companies/acet.md) (CIK 1720580)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-10
- Accepted by EDGAR: Apr 10, 2026, 20:27 ET
- Period: not reported
- Accession: 0000947871-26-000427
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1720580/000094787126000427/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1720580/000094787126000427/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1720580/000094787126000427/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 10, 2026.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000427. Last ingested by Listed: Nov 14, 2026, 19:00 ET. No prices; not investment advice.
